|
Re-sending of this newsletter to any number of colleagues is encouraged provided you also cc: report@medsuds.com. In return, we will invite recipients to subscribe. Any other unauthorized re-distribution is a violation of copyright law. Subscribe to the MedSuds Report at http://www.netsuds.net/mail.htm. You can get the web versions of these reports at http://www.medsuds.com/report/. In this Issue: 1.0 Heard on the Net 1.0 People And Companies On The Move: CLICK HERE FOR PEOPLE AND COMPANIES ON THE MOVE In the past, we've published information about people and companies on the move in our monthly report. Now you can publish and view that information instantly on our web log (blog)! To view, click on http://medicalsudsannounce.blogspot.com/. You can report a change in your job status if you are moving from or to a company in the medtech, biotech or life sciences markets. Include your new work contact information, not just your personal contact information. If you don't want to use the BLOG, send me an email at onthemove@medsuds.com. I'll publish the information for you. If you are with a 'company on the move', email onthemove@medsuds.com to report (1) the formation of a new start-up, (2) momentum change at an existing start-up, (3) addition of key hires, or (4) a funding event at a start-up. We do not accept press releases from third parties. We must hear directly from a company that is ‘on the move’. You can include a 80 x 100 pixel (width x height) photo in JPG or GIF format. Why email only to your small email list of associates when you can post this information on the blog and have 2500+ MedSudsers view it. To publish to the blog send me an email requesting permission. After you have an account, you can post to the blog as much as you want. You need only follow some common sense guidelines, e.g. don't post every press release, don't post sales information, don't post defamatory statements, etc. If you "spam" the blog, you will be removed. 2.0 Jobs in the "medtech, biotech and life sciences" Market Please email: matt@medsuds.com to report job openings in the medtech, biotech and life sciences market. In the body of the message, provide the name of the company and a URL link to the job postings.
3.0 Schedule of Events You can also try our online calendar by clicking here for NetSuds and here for MedSuds. The web calendars for NetSuds and MedSuds continue to grow in popularity as more and more people use them for the definitive place to find high-tech events in the Twin Cities. The calendars are free to use for both tracking events and for posting your own events. To post events, login as "guest" with a password of "guest". The Calendars are accessed at
NetSuds -
http://www.netsuds.net/cgi-bin/calweb/calweb.pl?cal=default Non-Minnesota companies conducting events in Minnesota will not be allowed to post events for free. Events posted to either of these calendars are not immediately available for viewing. All events will be marked "pending" and will be reviewed for content prior to public viewing.
4.0 Tidbits
MedSuds welcomes tours of
your facility! Email us if you want to show off your company. Contact
Janet Rebman Lillevold at
janet@medsuds.com. No tours this month. 4.2
Email Advertising
The
NetSuds
(5500+) and
MedSuds
(2600+)
email lists reach 8000+. The
NetSuds
email lists are double-opt-in and concentrated on professionals in the
communications, IT and Internet markets. The
MedSuds email lists are
double-opt-in and concentrated on professionals in the medtech, biotech and
life sciences markets. So, rather than spend your
advertising dollars on any other email lists in the Twin Cities, consider the
NetSuds and
MedSuds
lists. Contact
matt@medsuds.com or 612.605.5252. For current ad rates, visit
www.netsuds.com/adrates.htm. See the following URL for more information on our executive
search service -
www.medicalsuds.com/search/.
4.4
MedSuds
CEO Roundtable - Next Roundtables starting in June 2004
MedSuds
is opening up another group of CEO Roundtables in June 2004. If you are tech or medtech CEO and want to join us, (the
first session is free), contact
matt@medsuds.com. A synopsis of the CEO
Roundtable can be found at
www.medsuds.com/ceo/ It is repeated here
as well.
MedSuds
CEO Roundtable Membership Only CEOs of tech and
medtech companies are allowed to join the
MedSuds
CEO Roundtable. If you are a VP, CxO or President, you are not welcome
unless you also hold the CEO title.
If you are interested in becoming a member, contact
matt@medsuds.com.
Membership is not automatic. There must be an available spot open in the
roundtable. You must have employees. Your company must be
incorporated. Your company must be a tech (communications, IT,
software, Internet) or medtech (medtech, biotech, life sciences) company. You
must pay a yearly fee of $1200 in advance. You may not send substitutes to the
Roundtable. Roles Unlike the days of knights,
kings and Camelot, there is no king of the
MedSuds
CEO Roundtable; only a facilitator; Matt Noah, CEO of NetSuds.com, Inc.
Knights are replaced by CEOs and the table won't be quite round. Schedule The Roundtable will meet at least 10
times per calendar year. We meet the last
Tuesday of every month. Each meeting lasts between 2 hours starting at 7 am. A facility
convenient to the majority of Roundtable members is used. A continental breakfast
is served. Purpose CEOs need resources to
assist them in executing their duties and leading their companies. Boards
of Directors and upper management are not always the best or most independent
resources upon which to draw. The CEO Roundtable exists to provide CEOs
with an independent resource of wisdom and shared experience. Your key
'take-aways' from the Roundtable will be accelerated learning - so as to avoid
common and uncommon pitfalls -, an expanded network of advisors and colleagues
and tools to enhance the productivity and value of your enterprise. Content First, networking among the
CEO members of a Roundtable is the best and richest content. Second, the
Roundtable facilitator will schedule subject matter experts of interest to the
CEOs. Examples include intellectual property, branding, sales,
engineering, marketing, finance, compensation, human resources, M&A, etc. Format Meetings consist
primarily of 2 elements. First, "content" will be presented and discussed.
Second, "discussion" of common problems and solutions will take place. The
facilitator will lead both elements or assign elements to certain CEOs. Confidentiality Roundtable meetings
are completely confidential. Nothing said in a roundtable discussion,
short of illegal activity, leaves the meeting. This allows each CEO to
feel comfortable discussing issues and subjects he may not feel comfortable
speaking about with others. 4.5
Capital Formation Institute Office of Science, Technology Transfer and Economic Outreach University
at Buffalo, 1576 Sweet Home Rd., Amherst, NY 14228 May 25, 2004 Press Release for Immediate Release NASVF and CFI Jointly Announce the Creation of the Capital Formation
Institute as an Affiliated Non-Profit Research Organization The National Association of Seed and Venture Funds joins with the Capital
Formation Institute in announcing the creation of a new non-profit
organization dedicated to research in early-stage capital formation and
enterprise creation. CFI Mission Statement (adopted by CFI Board Nov. 3, 2003) The mission of CFI is to become the premier international research and
educational entity in the fields of early stage capital financing and
enterprise creation and growth. This mission will be accomplished by
sponsoring and conducting leading edge research projects, by recruiting
researchers, by soliciting program and project funding support from both
public and private sources, and by organizing and conducting educational
conferences, seminars, and workshops in the U.S. and worldwide (based upon
this research). CFI Management Team CFI is currently managed by its Corporate Board of Directors and is
assisted by a volunteer Research Advisory Board. Current Board Members are:
Dr. Richard T. Meyer, Chairman; Woodrow Maggard, President; Charles J.
Spies, Secretary-Treasurer; Steve Grizzell, and John W. Sibert. The Board of
Directors is in the process of being expanded to a board of 12 to 15 persons
that represent corporations, capital investment firms, federal
organizations, universities, research entities, and entrepreneurs. The Board
will be responsible for setting policy, programmatic goals, and fund-raising
targets for CFI. It will be composed of persons that can provide the
expertise and prestige required of CFI to achieve its goals. The Research Advisory Board (RAB) exists to serve the Corporate Board and
the Executive and Research Directors. It is composed of persons from
throughout the communities of early-stage capital investors, researchers,
and business creation. The RAB will help CFI to set research priorities, to
review research proposals, to allocate research funds, and to review ongoing
and completed research projects. Current RAB members are: Mr. Michael
Cassidy; Dr. Robert S. Schwartz; Dr. Joseph E. McCann III; Dr. William E.
Wetzel, Jr.; Dr. Frank Hoy; and Dr. Patricia Greene. CFI Products and Services CFI's products and services to those engaged in early-stage capital
financing, business creation, and entrepreneurship will consist of the
following: 1. Sponsored research (research funded by outside organizations) The first CFI research project will be to conduct a survey of public and
private early-stage capital funds somewhat analogous to a series of surveys
conducted by Dr. Meyer from 1986 through 1998. Fund managers who would like
to be included in this survey process should so indicate to Dr. Meyer at
OrionRTM@aol.com. Persons who have suggestions for future research projects to be conducted
by CFI may submit their topics to Dr. Meyer (505-343-9500) or any of the
Corporate Board or Research Advisory Board members.
4.6 Embryonic Stem Cell
Research Morality I am interested in publishing your opinions
and essays on the morality of ESCR. Email me your essays and opinions
on this subject and I'll print them in the July 1 MedSuds Monthly Report.
If there is enough interest, MedSuds will sponsor an event on this subject.
The essays and opinions can be of any length.
matt@medsuds.com.
5.0
Software Cooperatives - A New Paradigm For Rapid, Cost-Effective Development Corporate Collaboration Avalanche Gaining Momentum by
MedSudser
Mike Ellsworth,
mellsworth@stratvantage.com Is your enterprise grumbling over symptoms like forced
software upgrades, sunsetted software that is no longer supported, and hefty
annual maintenance fees that deliver little ROI? Do you get the feeling that
you’re duplicating the effort of dozens of companies like yours whenever you
upgrade an enterprise system or suffer through a desktop operating system
upgrade? Three years ago, a group of local CIOs decided to do
something about their lack of control over mission-critical software. “A lot of us are really sick of getting jerked around by
software companies,” says Andrew Black, CIO of Jostens. “We’ve tied our
destiny to sets of technical products that we don’t control.” So rather than continue to complain, Black and several of
his peers from Best Buy, ePredix, Integral Business Systems, and
Born decided to
band together and create their own medicine to get more value for the money they
were investing in application software. The result is the Avalanche Corporate
Technology Cooperative, a new concept in enterprise software. Avalanche is a
collaborative initiative that aims to reduce the cost and increase control over
corporate software. According to a survey by CIO.com (2001), almost half of the
IT professionals surveyed were unsatisfied with the quality of their business
software. Commercial enterprise software implementation projects are plagued by
delays and complexity, and companies struggle to stay current with the latest
revisions. With on-going support costs comprising almost 40 percent of the
overall expense of an ERP solution’s 3 year TCO (META Group), it’s no wonder
CIOs are desperately looking for ways to improve the ROI of existing software.
It does not appear the software vendors share this goal. Therefore, corporations
are spending more and receiving less ROI:
•
Corporations spend billions of dollars annually on software
licenses with marginal ROI
•
Total cost of ownership over five years is up to 20 times the
initial software license
•
Corporations are forced into vendor upgrades (averaging less than
every three years) incurring significant cost
•
This year, IT infrastructure cost will surpass facilities
infrastructure cost in 20 percent of global enterprises Faced with all these rising costs, CIOs have no choice but
to do more with less, striving to achieve higher levels of productivity from
their staffs. But higher productivity is not the only possible solution
to the CIO’s dilemma. What if IT staffs could spend time developing only the
unique and competitiveness-enhancing portions of the business’ applications and
infrastructure? What if they didn’t have to duplicate the same efforts that
dozens or hundreds of other similar companies are doing? What if the concept of
reusability could be extended outside the enterprise to leverage efforts and
assets of peers? The result would be less work for IT staff, increased
innovation, and a more collaborative approach to the problems every corporation
has. For example, each corporation’s Oracle version upgrade is
fundamentally similar, with only a small percentage of tasks being unique to the
implementation. Rather than each company expending time, effort, and money
developing project plans, methodologies, and procedures for accomplishing
similar tasks, the Avalanche concept allows corporations to collaborate to
create best demonstrated practices that can be shared among members.
Thus, one member company can contribute an upgrade plan to
the Cooperative, as Jostens has done. Other members can use and improve the
plan, and contribute it back to the Repository, thus adding value to the
original member’s effort. That’s the concept at the center of Avalanche’s mission: To
provide a framework to allow corporations to share operational software, plans,
and techniques and thus reduce the cost of their own IT efforts and improve
their ROI. But Avalanche goes beyond this concept by allowing members
of the Cooperative to harness the strength of numbers to not only share
intellectual property (IP), but also to collaborate on projects that generate
new IP. Its subscriber agreement enables IP to be shared by and between the
Cooperative and its members as well as enabling its members to collaborate
without legal liability risks. Membership is open to corporate “IT consumers” as
well as consultants and hardware and software vendors. “From the commercial vendor standpoint, Avalanche can be
like a user group on steroids,” Jay Hansen, Avalanche CEO says. “We’re talking
to major software vendors about the benefits of their membership in Avalanche.”
Indeed the collaboration infrastructure Avalanche has put into place can offer
tremendous value to vendors who may find it difficult to connect so directly
with their major customers. Collaborative Commerce One collaborative model that inspired Avalanche’s approach
is the Open Source model, which has been actively used by various organizations
since the mid-1980s. There is no doubt that Open Source software such as Linux
has made a big impact on corporate computing over the past few years. In a
survey of InfoWorld’s CTO Network, only 28 percent of respondents said they were
not using or planning to use Open Source software. The Open Source model has many benefits as well as
weaknesses. Advocates argue that the benefits such as cost, control, and
sharing (both risk and knowledge) far outweigh the weaknesses. However,
leveraging the Open Source model in a corporate mission critical environment has
been challenging. Black says “I think originally we thought we’d go out and find
a lot of open source applications to run off the shelf, but we found they were
really lightweight and I wouldn’t trust my company to them. I need a longer life
span for my applications than I think the open source community is targeting.” Although the idea of Avalanche adopting Open Source
software was a non-starter, the rich, collaborative environment of Open Source
software development was attractive. “The development model of Open Source
software is wonderful,” says Turbolinux Chief Executive Ly-Huong Pham said in a News.com article. “But let’s not confuse a development model with a business
model. Basic business principles were forgotten by some.” Avalanche did take some important concepts from the Open
Source movement, including the idea of collaborative source, a shared code base
enhanced by members and available for use exclusively by the membership, rather
than the public at large. And several other Open Source concepts underlie the
Cooperative’s approach, including the idea of leveraging the collective
knowledge of a large body of developers. “One-to-one collaboration is pretty inefficient and doesn’t
scale well,” according to Black. “With a Web-based collaboration platform like
Avalanche, companies all over can take advantage of a project plan or what my
team has learned about getting a particular set of applications to work
together. Avalanche is about scaling up collaboration.” Innovative Licensing Agreement One of the most significant achievements of Avalanche is
the software licensing agreement that governs the use of the IP in the
Repository. Painstakingly crafted with the assistance of law firm Dorsey &
Whitney, the software license allows Avalanche to indemnify members against any
intellectual property infringement claim from third parties. Any contributed IP goes through a rigorous inspection and
certification process that identifies and mitigates any real or potential IP
infringement. Once certified, the IP is protected by the licensing agreement and
members can use the software for internal purposes without fear of infringement
claims. In a business environment where a vendor is litigating against users of
Linux, this protection is comforting. One annual membership fee gives Avalanche members
“All you can eat”
access to all products and services offered by the Cooperative including: IT consumer companies, consultants and vendors all can join Avalanche as full
members, and there are benefits for each of these categories. Avalanche’s
by-laws clearly state, however, that the Cooperative exists primarily for IT
consumer members. Two-thirds of its board members, at a minimum, need to be IT
consumers. Its software is distributed to all of its members, including
vendors, but its by-laws also state that all members must use the IP for
internal use only and it cannot be shared with non-Cooperative members. Avalanche expects and
encourages competing companies to join Avalanche. They remind companies that
their competitors already have access to all the commercial software they
buy and run, and the fact that Ford and GM, for example, both use Oracle has
little effect on their competitiveness with one another. Having access to
commercial software, or to software from the Cooperative, does not guarantee
a competitive advantage. “It’s how you use it that differentiates your
competitive advantage, not the application itself,” says Black. “If I’m
OK with being in an SAP user group with competitors, why wouldn’t I be OK
with sharing other kinds of intellectual property as well?” “We think our approach has the capability of
revolutionizing the way we conduct IT,” says Elmer Baldwin, CEO of Born.
“Done correctly, you can imagine a very different landscape a decade out. If you
add up all the IT professionals in industry, we vastly outnumber the number of
people in the software industry making products. Why can’t we leverage the power
of the hundreds of thousands of developers out there who are busy making
applications that are sitting inside our four walls? Just from a raw numbers
game, being able to leverage the power that corporate IT is bringing to the
table every single day is an industry-changing proposition.” For more information, contact: Jay
Hansen, CEO 6.0 From
Robust PPM’s to Term Sheet Milestones by
MedSudser Scott
Dowd,
skkowd@earthlink.net The Issue Putting together a baseline analysis for a funding opportunity is one thing, building on that analysis and designing a success track that can be implemented, and executed on after a funding event takes place is often not given enough consideration. Accountability for daily movement towards Term Sheet growth and revenue objectives is critical. The ability to develop a funded opportunity into a success is a challenge that derails many good intentioned companies. The majority of these opportunities fall by the way side because the organization is unable to establish, measure and manage to the core business objectives tied to revenue and market penetration. Once PPM or Private Placement Memorandums have been completed and Term Sheet objectives have been established. And after funding is provided, success and progress often times are slow in coming.. Why? It is not uncommon to realize that the existing sales pipeline in reality is not as strong as was initially believed, There is little idea as to the true profit levels on sales transactions, Or the competitive landscape is still a complete mystery, The sales staff may be lacking in adequate tools, support and skill sets, and as a result a perception develops that indicates lack of a clear plan that would allow for fair competition in the chosen marketplace, Companies tend to then become reactive as opposed to strategic in their pursuit of growth. Opportunity Analysis / Robust PPM Typically Private Placement Memorandum efforts begin and evolve around the following discovery areas. What is the background and experience of the leadership team, have they had prior successes in this particular industry. Has the organization been able to make some progress while also managing to keep the lights on – It seems that there is enough interest in the solution and that with the right amount of funding at the right time the client could really make a mark in their selected industry. The client has managed to gather a few wins with some customers that have name recognition or that are in a particular industry that is key to their solution and success. Pipeline – What is in the hopper – how much revenue potentially exists and over what period of time can that revenue be expected to come in? Competition – Where does the solution fit in the marketplace, and how does the solution compare and contrast. In short, PPM is not as robust as it needs to be. In order to gain a true barometer of your clients potential for success an Opportunity Analysis needs to supplement your PPM efforts and set the table for your Term Sheet objectives. It is a deeper layer. An Opportunity Analysis involves identification of trends, and looks at a variety of metrics including,. Which markets offer the best potential for the products or services right now. Who are the prime target customers, what is the true market potential, what is the competitive landscape? How does the solution or service match up? How does the competition sell and what is their compelling message? What are the pricing and margin trends? What established partnerships exist, And are there any recent press and or industry news releases, To name a few. **Please note. Funding opportunities present themselves at different stages, Seed, Growth, Later Stage, Mergers, Acquisitions and Liquidity level events – Each stage has different capabilities requirements, Trend analysis metrics and assessment processes that are required. Trend Analysis / Gap Analysis When accurately done, predictable trends will start to appear from the Opportunity Analysis, Compare and contrasting of existing competitive companies is an important part of the process here. Others have gone before you, They have left behind a trail of lessons learned. Look at their successes and failures and be able to identify and document the exact paths and results that need to be benchmarked. Even initial revenue expectations start to become apparent that are fairly accurate and will serve as a barometer for measurable success. Opportunity Roadmap / Execution The previous analysis will allow you now to build an Opportunity Roadmap that clearly sets some realistic objectives and milestones. Including identification of the prime prospects your client needs to target and speak with. What the typical pain points are of these prospects and what they may be most interested in buying. Good ideas, hot markets, and great technology will however mean nothing without follow on expert execution. An Opportunity Roadmap identifies 4 specific pursuit metrics. Direct Access Requirements, Based on profiling, these prospects represent the cream of the crop, they appear to be more ready than others to hear your message and require immediate attention. Leveraged Access Requirements, Represents the need to partner with organizations that have access to the clients and markets you want to penetrate, and because of their size and strength can exponentially provide growth opportunities thru their existing sales forces and contacts, Channel and OEM partnerships are prime examples of this. Opportunistic Requirements, Is the identification and participation in events such as key trade shows, industry events and key press notices. Supplemental Requirements, Involves the development of a common message and identity that can be translated throughout the effort. From the presentations used on sales calls to the marketing related materials in the field. And everything in between. Summary Executing daily on defined manageable objectives allows you to add depth and perspective to your PPM and drive Term Sheet objectives. After comprehensive discovery and planning, set achievable milestones and then assign someone to be held accountable to that pursuit while maintaining the joint interests of the funded company and the financial backing group. Without post funding execution all of your background and expectations can be of little use.. The company you are examining for funding should have a great management staff in place first and foremost so allow them to focus on growing the business, as great management teams should do. Have them build name recognition, develop key industry contacts and manage a solid R&D schedule, While someone like Engage provides Opportunity Analysis and Road Mapping and then drives the obligation of revenue and marketplace penetration. Engage is a premier sales outsourcing company focused on assisting high growth potential product and services companies. Our mission is to find the best prospects, understand what will motivate these prospects, and sell them our clients products and services. Engage is driven towards a single goal: “Generating Revenue for our Clients! Engage 763-428-7511 www.engagesales.com7.0 Guest Writers for This Report The MedSuds Monthly Report welcomes guest writers! If you have a passion for a topic, and you can write, send an email to janet@medsuds.com or matt@medsuds.com. You can even send copies of your work. It needs to be on med-tech, biotech or life sciences topics and can include entrepreneur/investor activities. Good information from our service providers and vendors is also welcome so long as it is not a "commercial" for any one company or individual. We will consider any qualified columnists and guest writers. If you are aware of others who would like to receive the
MedSuds Report, ask
them to visit
http://www.netsuds.net/mail.htm
to subscribe or
unsubscribe. |